NO158505C - Analogifremgangsmaate for fremstilling av et terapeutisk aktivt 7beta-substituert malonamido-1-oksadetia 7alfa-metoksy-3-(1-metyltetrazol-5-yl)-tiometyl cefalosporin. - Google Patents

Analogifremgangsmaate for fremstilling av et terapeutisk aktivt 7beta-substituert malonamido-1-oksadetia 7alfa-metoksy-3-(1-metyltetrazol-5-yl)-tiometyl cefalosporin.

Info

Publication number
NO158505C
NO158505C NO771023A NO771023A NO158505C NO 158505 C NO158505 C NO 158505C NO 771023 A NO771023 A NO 771023A NO 771023 A NO771023 A NO 771023A NO 158505 C NO158505 C NO 158505C
Authority
NO
Norway
Prior art keywords
tyomethyl
oxadadia
7alfa
malonamido
7beta
Prior art date
Application number
NO771023A
Other languages
English (en)
Norwegian (no)
Other versions
NO158505B (no
NO771023L (no
Inventor
Masayuki Narisada
Wataru Nagata
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3340176A external-priority patent/JPS52122386A/ja
Priority claimed from JP5029576A external-priority patent/JPS52133997A/ja
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NO771023L publication Critical patent/NO771023L/no
Publication of NO158505B publication Critical patent/NO158505B/no
Publication of NO158505C publication Critical patent/NO158505C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO771023A 1976-03-25 1977-03-23 Analogifremgangsmaate for fremstilling av et terapeutisk aktivt 7beta-substituert malonamido-1-oksadetia 7alfa-metoksy-3-(1-metyltetrazol-5-yl)-tiometyl cefalosporin. NO158505C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3340176A JPS52122386A (en) 1976-03-25 1976-03-25 Cephalosporin analogous compounds as antibacterials
JP5029576A JPS52133997A (en) 1976-04-30 1976-04-30 Cephalosporin antibiotics

Publications (3)

Publication Number Publication Date
NO771023L NO771023L (no) 1977-09-27
NO158505B NO158505B (no) 1988-06-13
NO158505C true NO158505C (no) 1988-09-21

Family

ID=26372085

Family Applications (2)

Application Number Title Priority Date Filing Date
NO771023A NO158505C (no) 1976-03-25 1977-03-23 Analogifremgangsmaate for fremstilling av et terapeutisk aktivt 7beta-substituert malonamido-1-oksadetia 7alfa-metoksy-3-(1-metyltetrazol-5-yl)-tiometyl cefalosporin.
NO862107A NO862107L (no) 1976-03-25 1986-05-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporin-derivater.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO862107A NO862107L (no) 1976-03-25 1986-05-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporin-derivater.

Country Status (19)

Country Link
AR (1) AR224606A1 (fr)
BG (1) BG31074A3 (fr)
CY (1) CY1158A (fr)
DD (1) DD129792A5 (fr)
DE (1) DE2713370C2 (fr)
DK (1) DK161331C (fr)
ES (5) ES457174A1 (fr)
GR (1) GR61146B (fr)
HK (1) HK46882A (fr)
HU (1) HU172720B (fr)
IE (1) IE44794B1 (fr)
IL (1) IL51743A (fr)
MX (1) MX4348E (fr)
NO (2) NO158505C (fr)
NZ (1) NZ183687A (fr)
PT (1) PT66346B (fr)
RO (2) RO71742A (fr)
SE (1) SE443143B (fr)
YU (2) YU44039B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1557552A (en) * 1977-02-15 1979-12-12 Shionogi & Co 1 oxadethiacepham compounds
US4252953A (en) * 1979-05-01 1981-02-24 Eli Lilly And Company Antibiotic crystalline epimer
JPS60123490A (ja) * 1983-12-07 1985-07-02 Shionogi & Co Ltd マロニルオキサセフェムカルボン酸誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL178005C (nl) * 1972-11-06 1986-01-02 Merck & Co Inc Werkwijze voor het bereiden van een farmaceutisch preparaat met antibacteriele werking, alsmede werkwijze ter bereiding van een cefalosporine-antibioticum.
US3962232A (en) * 1973-11-05 1976-06-08 Eli Lilly And Company 7-methoxycephalosporins
GB1449420A (en) * 1973-11-26 1976-09-15 Sankyo Co 7alpha-methoxycephalosporing derivatives

Also Published As

Publication number Publication date
DE2713370A1 (de) 1977-09-29
HU172720B (hu) 1978-11-28
HK46882A (en) 1982-11-19
DE2713370C2 (de) 1994-04-21
ES469286A1 (es) 1979-09-16
YU44038B (en) 1990-02-28
NZ183687A (en) 1979-01-11
YU173883A (en) 1983-12-31
YU173783A (en) 1983-12-31
DD129792A5 (de) 1978-02-08
RO78228A (fr) 1982-02-01
SE7703325L (sv) 1977-09-26
CY1158A (en) 1983-01-28
SE443143B (sv) 1986-02-17
DK161331B (da) 1991-06-24
NO862107L (no) 1977-09-27
IE44794L (en) 1977-09-25
ES469287A1 (es) 1979-09-16
GR61146B (en) 1978-09-27
NO158505B (no) 1988-06-13
MX4348E (es) 1982-04-05
PT66346B (en) 1978-08-16
YU44039B (en) 1990-02-28
AR224606A1 (es) 1981-12-30
RO71742A (fr) 1982-02-26
PT66346A (en) 1977-04-01
DK161331C (da) 1991-12-09
ES457174A1 (es) 1978-08-16
NO771023L (no) 1977-09-27
DK131277A (da) 1977-09-26
ES469284A1 (es) 1978-11-16
ES469285A1 (es) 1979-09-16
IL51743A (en) 1980-10-26
IE44794B1 (en) 1982-04-07
BG31074A3 (en) 1981-10-15

Similar Documents

Publication Publication Date Title
NO161117C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO149586C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO147950C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminoalkyl-heterocykliske forbindelser
NO156864B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO148453C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spirohydantoinderivater
NO150360C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacyldipeptider
NO153569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater.
NO156787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO159654C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater.
NO150044C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazol-derivater
NO145762C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser
NO150762C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt 1-aza-2-(2,2,2)-bicyklo-oktan
NO159591C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt karbostyrilderivat.
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO160512C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO771884L (no) Fremgangsm}te for fremstilling av terapeutisk aktive polyribonukleotider
NO154052C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater.
NO147523C (no) Analogifremgangsmaate ved fremstilling av et nytt terapeutisk aktivt piperidylindenderivat
SE440500B (sv) Forfarande for framstellning av optiskt aktiva antracyklinoner
NO146777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6h-indolo (3,2,1-de)-(1,5)-naftyridinderivater
NO159798C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporin-oksyder.